These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Phosphatidylinositol-3,4,5-trisphosphate: tool of choice for class I PI 3-kinases. Salamon RS; Backer JM Bioessays; 2013 Jul; 35(7):602-11. PubMed ID: 23765576 [TBL] [Abstract][Full Text] [Related]
9. Class I PI3-kinase or Akt inhibition do not impair axonal polarization, but slow down axonal elongation. Diez H; Benitez MJ; Fernandez S; Torres-Aleman I; Garrido JJ; Wandosell F Biochim Biophys Acta; 2016 Nov; 1863(11):2574-2583. PubMed ID: 27421985 [TBL] [Abstract][Full Text] [Related]
10. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452 [TBL] [Abstract][Full Text] [Related]
11. PTEN counteracts PIP3 upregulation in spines during NMDA-receptor-dependent long-term depression. Arendt KL; Benoist M; Lario A; Draffin JE; Muñoz M; Esteban JA J Cell Sci; 2014 Dec; 127(Pt 24):5253-60. PubMed ID: 25335889 [TBL] [Abstract][Full Text] [Related]
12. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase. Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157 [TBL] [Abstract][Full Text] [Related]
13. A new class of cancer-associated PTEN mutations defined by membrane translocation defects. Nguyen HN; Yang JM; Rahdar M; Keniry M; Swaney KF; Parsons R; Park BH; Sesaki H; Devreotes PN; Iijima M Oncogene; 2015 Jul; 34(28):3737-43. PubMed ID: 25263454 [TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling. Li H; Marshall AJ Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180 [TBL] [Abstract][Full Text] [Related]
15. Ligand-Biased Regulation of PtdIns(3,4,5)P3-Dependent Signal Transduction in GPCR Control of Pituitary Hormone Release. Pemberton JG; Chang JP Endocrinology; 2017 Feb; 158(2):378-401. PubMed ID: 27906555 [TBL] [Abstract][Full Text] [Related]
17. The regulation of cell migration by PTEN. Leslie NR; Yang X; Downes CP; Weijer CJ Biochem Soc Trans; 2005 Dec; 33(Pt 6):1507-8. PubMed ID: 16246156 [TBL] [Abstract][Full Text] [Related]
18. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. Reed DE; Shokat KM Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852 [TBL] [Abstract][Full Text] [Related]
19. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN. Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321 [TBL] [Abstract][Full Text] [Related]
20. The relation between PI3K/AKT signalling pathway and cancer. Noorolyai S; Shajari N; Baghbani E; Sadreddini S; Baradaran B Gene; 2019 May; 698():120-128. PubMed ID: 30849534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]